Citation Impact
Citing Papers
Single dose oral etoricoxib for acute postoperative pain in adults
2014
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee
2012 Standout
Leukotriene-receptor antagonists
1999
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines
2008 Standout
Montelukast, a Once-Daily Leukotriene Receptor Antagonist, in the Treatment of Chronic Asthma<subtitle>A Multicenter, Randomized, Double-blind Trial</subtitle>
1998
Salmeterol Powder Provides Significantly Better Benefit Than Montelukast in Asthmatic Patients Receiving Concomitant Inhaled Corticosteroid Therapy
2001
Mast cells: Beyond IgE
2003
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
2004
GRADE guidelines: 7. Rating the quality of evidence—inconsistency
2011 Standout
Mild asthma: an expert review on epidemiology, clinical characteristics and treatment recommendations
2007
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Some statistical methods for multiple endpoints in clinical trials
1997
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
2005 Standout
Protective immune mechanisms in helminth infection
2007 Standout
Leukotriene antagonism in asthma and rhinitis
1998
Pulmonary immune cells in health and disease: the eosinophil leucocyte (Part II)
1994
Leukotrienes as mediators of airway obstruction and inflammation in asthma
1995
IgE and mast cells in allergic disease
2012 Standout
Upper gastrointestinal bleeding in haemophiliacs: incidence and relation to use of non‐steroidal anti‐inflammatory drugs
2007
Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003
2004 Standout
Treatment of Asthma with Drugs Modifying the Leukotriene Pathway
1999
Cholecystokinin antagonists: Pharmacological and therapeutic potential
2003
Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma
2007
Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma Prevention
2005 Standout
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
2006 Standout
Plants as source of drugs
2001 Standout
Asthma
2017 Standout
Gastrointestinal tolerability of etoricoxib in rheumatoid arthritis patients: results of the etoricoxib vs diclofenac sodium gastrointestinal tolerability and effectiveness trial (EDGE-II)
2007
Inflammation and Colon Cancer
2010 Standout
Impact of a Soluble Phospholipase A2Inhibitor on Inhaled Allergen Challenge in Subjects with Asthma
2005
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents
2020 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
The growing impact of click chemistry on drug discovery
2003 StandoutNobel
The development of allergic inflammation
2008 StandoutNature
Circadian control of the immune system
2013 Standout
Adjusting for multiple testing—when and how?
2001 Standout
Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy
2014 Standout
Eicosanoids and asthma: an update
1995
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
Non-steroidal anti-inflammatory drugs and myocardial infarctions: comparative systematic review of evidence from observational studies and randomised controlled trials
2007
Management of Patients With Ulcer Bleeding
2012 Standout
Structures of membrane proteins
2010 StandoutNobel
Management of acute haemarthrosis in haemophilia A without inhibitors: literature review, European survey and recommendations
2011
Addition of leukotriene antagonists to therapy in chronic persistent asthma: a randomised double-blind placebo-controlled trial
2001
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
5-Substituted-1H-tetrazoles as carboxylic acid isosteres: medicinal chemistry and synthetic methods
2002 Standout
Rheumatoid arthritis
2010 Standout
Indirect airway challenges
2003
Coxibs, non‐steroidal anti‐inflammatory drugs and cardiovascular risk
2006
A single-blind, randomized, controlled trial to assess the efficacy and tolerability of rofecoxib, diclofenac sodium, and meloxicam in patients with acute gouty arthritis
2004
Minimizing complications from nonsteroidal antiinflammatory drugs: Cost‐effectiveness of competing strategies in varying risk groups
2005
Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases
2008 Standout
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view
2017 Standout
CURCUMIN: THE INDIAN SOLID GOLD
2007 Standout
Antileukotrienes in asthma: present situation
2001
Gastrointestinal Safety of Cyclooxygenase-2 Inhibitors: A Cochrane Collaboration Systematic Review
2007
Distribution of therapeutic response in asthma control between oral montelukast and inhaled beclomethasone
2003
The Lipoxygenases: Their Regulation and Implication in Alzheimer’s Disease
2015
Mast cells and eicosanoid mediators: a system of reciprocal paracrine and autocrine regulation
2007
A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry
2014 Standout
Industry sponsorship and research outcome
2012 Standout
Asthma
2000 Standout
Montelukast Added to Inhaled Beclomethasone in Treatment of Asthma
1999
Leukotriene Modifier Therapy for Mild Sleep-disordered Breathing in Children
2005
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
Risk of cardiovascular events and rofecoxib: Cumulative meta-analysis
2005
Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma
2003
Evolution of a series of non-quinoline leukotriene D4 receptor antagonist; synthesis and sar of benzothiazoles and thiazoles substituted benzyl alcohols as potent LTD4 antagonists
1995
Addition of anti-leukotriene agents to inhaled corticosteroids for chronic asthma
2004
Recent Natural Products Based Drug Development: A Pharmaceutical Industry Perspective
1998
Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2012 Standout
Oral Montelukast Versus Inhaled Beclomethasone in 6- to 11-year-old Children with Asthma: Results of an Open-label Extension Study Evaluating Long-term Safety, Satisfaction, and Adherence with Therapy
2001
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
2001 StandoutScience
Pharmacological and immunohistochemical evidence for a functional nitric oxide synthase system in rat peritoneal eosinophils
1997 StandoutNobel
Chemoselective Synthesis of Polysubstituted Pyridines from Heteroaryl Fluorosulfates
2016 StandoutNobel
Interventions for enhancing medication adherence
2014 Standout
Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.
2008
Leukotriene Modifiers in Pediatric Asthma Management
2001
Oral Montelukast, Inhaled Beclomethasone, and Placebo for Chronic Asthma
1999
Natural product and natural product derived drugs in clinical trials
2014 Standout
Receptors for Purines and Pyrimidines
2012 Standout
Intranasal Steroids and Oral Leukotriene Modifier Therapy in Residual Sleep-Disordered Breathing After Tonsillectomy and Adenoidectomy in Children
2006
Inhibition by Leukotriene Inhibitors, and Calcium and Platelet-activating Factor Antagonists, of Acute Gastric and Intestinal Damage in Arthritic Rats and in Cholinomimetic-treated Mice
1999
Abdominal Aortic Aneurysm
2006 Standout
Phospholipase A2Enzymes: Physical Structure, Biological Function, Disease Implication, Chemical Inhibition, and Therapeutic Intervention
2011 Standout
Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children
2012
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
2008
Effects of montelukast (MK-0476); a potent cysteinyl leukotriene receptor antagonist, on bronchodilation in asthmatic subjects treated with and without inhaled corticosteroids
1997
Cysteinyl Leukotrienes and Their Receptors: Cellular Distribution and Function in Immune and Inflammatory Responses
2004
CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials
2010 Standout
Guidelines for the management of hemophilia
2012 Standout
Industry sponsorship and research outcome
2017 Standout
Effect of Treatment With Zileuton, a 5-Lipoxygenase Inhibitor, in Patients With Asthma
1996
Diagnosis and Management of Childhood Obstructive Sleep Apnea Syndrome
2012 Standout
Prevention of NSAID-related upper gastrointestinal toxicity: a meta-analysis of traditional NSAIDs with gastroprotection and COX-2 inhibitors
2009
Works of Sumiko Shingo being referenced
Pharmacokinetics and pharmacodynamics of multiple oral doses of MK-0591, a 5-lipoxygenase—activating protein inhibitor
1994
Oral Leukotriene Inhibitor (MK-886) Blocks Allergen-induced Airway Responses
1993
The gastrin-receptor antagonist L-365,260 inhibits stimulated acid secretion in humans
1993
Renal effects of etoricoxib and comparator nonsteroidal anti-inflammatory drugs in controlled clinical trials
2004
Acute Bronchodilation with an Intravenously Administered Leukotriene D 4 Antagonist, MK-679
1993
Effect of Montelukast on Single-Dose Theophylline Pharmacokinetics
1998
A placebo and active comparator-controlled trial of rofecoxib for the treatment of rheumatoid arthritis
2002
Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ≥ 6 years
2001
A placebo-controlled, dose-ranging study of montelukast, a cysteinyl leukotriene–receptor antagonist
1998
The analgesic effect of etoricoxib relative to that of two opioid-acetaminophen analgesics: a randomized, controlled single-dose study in acute dental impaction pain
2005
Analysis of montelukast in mild persistent asthmatic patients with near-normal lung function
2001
Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy
2005
A Standardized Composite Clinical Score for Inhaled Corticosteroids Taper Studies in Asthma
2002
P44 Statistical issues in the design and analysis of clinical trials evaluating therapy for chronic asthma
1993